Next Article in Journal
Prevalence of Diamine Oxidase Enzyme (DAO) Deficiency in Subjects with Insomnia-Related Symptoms
Previous Article in Journal
Relationship between Countermovement Jump and Sprint Performance in Professional Football Players
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
JCM
Volume 13
Issue 16
10.3390/jcm13164582
jcm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Correction to J. Clin. Med. 2024, 13(4), 943.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Ferri et al. Low-Density Lipoprotein Cholesterol-Lowering Drugs: A Narrative Review. J. Clin. Med. 2024, 13, 943

by
Nicola Ferri
1,2,*,
Massimiliano Ruscica
3,4,*,
Sergio Fazio
5 and
Alberto Corsini
3
1
Department of Medicine (DIMED), University of Padova, 35122 Padova, Italy
2
Veneto Institute of Molecular Medicine (VIMM), 35129 Padua, Italy
3
Department of Pharmacological and Biomolecular Sciences “Rodolfo Paoletti”, University of Milan, 20133 Milan, Italy
4
Department of Cardio-Thoracic-Vascular Diseases, Foundation IRCCS Cà Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy
5
Regeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA
*
Authors to whom correspondence should be addressed.
J. Clin. Med. 2024, 13(16), 4582; https://doi.org/10.3390/jcm13164582
Submission received: 16 July 2024 / Accepted: 24 July 2024 / Published: 6 August 2024
(This article belongs to the Section Cardiology)
Review Reports Versions Notes

Text Correction

There was an error in the original publication [1]. No dose adjustment is necessary in patients with mild hepatic impairment (Child–Pugh A), while its use is not recommended in patients with moderate (Child–Pugh B) or severe (Child–Pugh C) hepatic impairment [127].
A correction has been made to 6. Bempedoic Acid, 6.3. Pharmacokinetics:
No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child–Pugh A or Child–Pugh B). Since no data are available in patients with severe hepatic impairment (Child–Pugh C), they should undergo periodic liver function tests.
References
The original reference [127] has become [132]. Thus, all the references between [127] and [132] have been renumbered accordingly.
The new references are as follows:
127. De Filippo, O.; D’Ascenzo, F.; Iannaccone, M.; Bertaina, M.; Leone, A.; Borzillo, I.; Ravetti, E.; Solano, A.; Pagliassotto, I.; Nebiolo, M.; et al. Safety and efficacy of bempedoic acid: A systematic review and meta-analysis of randomised controlled trials. Cardiovasc. Diabetol. 2023, 22, 324. https://doi.org/10.1186/s12933-023-02022-z.
128. Ray, K.K.; Bays, H.E.; Catapano, A.L.; Lalwani, N.D.; Bloedon, L.T.; Sterling, L.R.; Robinson, P.L.; Ballantyne, C.M.; Trial, C.H. Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol. N. Engl. J. Med. 2019, 380, 1022–1032. https://doi.org/10.1056/NEJMoa1803917.
129. Singh, J.A.; Reddy, S.G.; Kundukulam, J. Risk factors for gout and prevention: A systematic review of the literature. Curr. Opin. Rheumatol. 2011, 23, 192–202. https://doi.org/10.1097/BOR.0b013e3283438e13.
130. Ray, K.K.; Nicholls, S.J.; Li, N.; Louie, M.J.; Brennan, D.; Lincoff, A.M.; Nissen, S.E. Efficacy and safety of bempedoic acid among patients with and without diabetes: Prespecified analysis of the CLEAR Outcomes randomised trial. Lancet Diabetes Endocrinol. 2023, 12, 19–28. https://doi.org/10.1016/S2213-8587(23)00316-9.
131. Ferri, N.; Corsini, A. Mechanism of bempedoic acid induced cholelithiasis: A role for statins to limit this adverse effect? Pharmacol. Res. 2023, 196, 106900. https://doi.org/10.1016/j.phrs.2023.106900.
132. Nilemdo: Summary of Product Characteristics. 2023. Available online: https://www.ema.europa.eu/en/documents/product-information/nilemdo-epar-product-information_en.pdf (accessed on 1 February 2024).
With this correction, the order of some references has been adjusted accordingly. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Ferri, N.; Ruscica, M.; Fazio, S.; Corsini, A. Low-Density Lipoprotein Cholesterol-Lowering Drugs: A Narrative Review. J. Clin. Med. 2024, 13, 943. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Ferri, N.; Ruscica, M.; Fazio, S.; Corsini, A. Correction: Ferri et al. Low-Density Lipoprotein Cholesterol-Lowering Drugs: A Narrative Review. J. Clin. Med. 2024, 13, 943. J. Clin. Med. 2024, 13, 4582. https://doi.org/10.3390/jcm13164582

AMA Style

Ferri N, Ruscica M, Fazio S, Corsini A. Correction: Ferri et al. Low-Density Lipoprotein Cholesterol-Lowering Drugs: A Narrative Review. J. Clin. Med. 2024, 13, 943. Journal of Clinical Medicine. 2024; 13(16):4582. https://doi.org/10.3390/jcm13164582

Chicago/Turabian Style

Ferri, Nicola, Massimiliano Ruscica, Sergio Fazio, and Alberto Corsini. 2024. "Correction: Ferri et al. Low-Density Lipoprotein Cholesterol-Lowering Drugs: A Narrative Review. J. Clin. Med. 2024, 13, 943" Journal of Clinical Medicine 13, no. 16: 4582. https://doi.org/10.3390/jcm13164582

APA Style

Ferri, N., Ruscica, M., Fazio, S., & Corsini, A. (2024). Correction: Ferri et al. Low-Density Lipoprotein Cholesterol-Lowering Drugs: A Narrative Review. J. Clin. Med. 2024, 13, 943. Journal of Clinical Medicine, 13(16), 4582. https://doi.org/10.3390/jcm13164582

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop